The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Prostate Cancer Drugs Global Market Report 2023, the prostate cancer drugs market is expected to show significant growth in the forecast period.

Key insights from the prostate cancer drugs market forecast include:

1. Market Size

The global prostate cancer drugs market is expected to grow from $17.63 billion in 2022 to $18.81 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The global prostate cancer drugs market size is expected to grow to $23.50 billion in 2027 at a CAGR of 5.7%.

2. Major Driver

The growing geriatric male population is a primary driving force in the prostate cancer medications industry. Prostate cancer is one of the most prevalent cancers in men over the age of 60. According to ACL (Administration For Community Living), a federal organisation established in the United States, the geriatric population is predicted to grow by 21.6% by 2040. Men are more affected by prostate cancer than women in this demographic.According to the American Cancer Society, a US-based organisation, prostate cancer will be diagnosed among older men and non-hispanic black males in January 2022.and around 6 out of every 10 instances are diagnosed in men aged 65 and up (geriatric group). As a result, the growing geriatric male population drives the prostate cancer market.

View More On The Prostate Cancer Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

3. Key Trend

The use of combination therapy to treat prostate cancer is a new market trend. This is primarily due to the fact that monotherapy has not been beneficial in some cases of prostate cancer. Companies in the prostate cancer medications market are investing more in combination therapy for the treatment of prostate cancer in this regard. Pfizer, for example, announced the results of its Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC), which show that using XTANDI (enzalutamide) in combination with androgen deprivation therapy (ADT) reduced the risk of developing metastases or death by 71% compared to ADT alone. Similarly, additional combination therapies are being utilised to treat prostate cancer, such as a combination of radiation therapy and androgen deprivation therapy for men with recurrent prostate cancer, and employing the chemotherapeutic medication docetaxel (Taxotere) in conjunction with ADT.

4. Largest Region

North America was the largest region in the prostate cancer drugs market in 2022.

5. Major Players

Major players in the food diagnostics market are Astellas Inc., AstraZeneca PLC., Johnson & Johnson, Sanofi S.A, Bayer AG, Roche, Abbott, Pfizer, Norvaris and F. Hoffmann-La Roche AG.

Request A Sample Of The Global Prostate Cancer Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2592&type=smp

Key Prostate Cancer Drugs Market Segments
1) By Type: Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer
2) By Therapy: Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy
3) By End User: Hospitals, Clinics, Other End-Users

The Prostate Cancer Drugs Global Market Report 2023  provides an in-depth analysis on the prostate cancer drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the prostate cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Drugs For Erectile Dysfunction Global Market Report 2023
Cancer Diagnostics Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model